当科の研究が英文誌「Diabetes Therapy」に掲載されました。
Fumika Shigiyama, Shigenori Hiruma, Shinji Hisatake, Nobuyuki Shiraga, Takanori Ikeda, Takahisa Hirose, Naoki Kumashiro.
Rationale, Design for the ASSET Study: A prospective randomized study comparing empagliflozin’s effect to sitagliptin on cardiac fat accumulation/function in patients with type 2 diabetes
